Microbot Medical
MBOT
29 hedge funds and large institutions have $2.94M invested in Microbot Medical in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
21% more funds holding
Funds holding: 24 → 29 (+5)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
0.92% less ownership
Funds ownership: 18.87% → 17.95% (-0.92%)
30% less capital invested
Capital invested by funds: $4.2M → $2.94M (-$1.26M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$68.8K |
| 2 |
Millennium Management
New York
|
+$44K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$8.93K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.82K |
| 5 |
Morgan Stanley
New York
|
+$8.14K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$266K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$77.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$26.9K |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$2.66K |
| 5 |
Bank of New York Mellon
New York
|
-$444 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFSG
26
Newbridge Financial Services Group
Boca Raton,
Florida
| $2 | – | – | – |
|
|
NA
27
NewEdge Advisors
New Orleans,
Louisiana
| $2 | – | – | – |
|
28
Fidelity Investments
Boston,
Massachusetts
| – | -$3 | -1 | Closed |
|
|
FRA
29
Front Row Advisors
Tiburon,
California
| – | +$3 | +1 | New |
|
30
Simplex Trading
Chicago,
Illinois
| – | +$888 | +300 | New |
|
MBOT Hedge Fund Activity: Q1 2023 in Review
29 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2023, worth a combined $2.94M — down 30% from $4.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new MBOT positions and 1 closed out — a net gain of 5 holders — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $68.8K. The largest seller was Armistice Capital, cutting an estimated $266K.
- 29 institutional investors held Microbot Medical (MBOT) as of Q1 2023, up from 24 in Q4 2022.
- Funds reported $2.94M of Microbot Medical stock for Q1 2023, down 30% quarter-over-quarter.
- 6 funds opened new Microbot Medical positions in Q1 2023 and 1 closed out, a net change of +5 holders.
- The largest Microbot Medical buyer in Q1 2023 was Citadel Advisors, an estimated $68.8K added.
- The largest Microbot Medical seller in Q1 2023 was Armistice Capital, an estimated $266K sold.
Based on aggregated 13F filings for Q1 2023.